Arkis BioSciences is a high-tech medical device company founded by Chad Seaver, a UT alumnus. The company offers a portfolio of neurosurgical tools and advanced catheters that streamline surgeries, reduce risks, enhance treatment outcomes and lower the overall cost of care.
From developing a strapless CPAP device for sleep apnea to using bioluminescent zebrafish as a tool for drug screening, the University of Tennessee Research Foundation’s Maturation Funding program has helped researchers develop technologies with potential for commercial use.
Most diagnostic devices on the market today are expensive and can take hours or even several days to provide results. Since 2009, Jayne Wu and Shigetoshi Eda have been collaborating to develop a low-cost device that is easy to use, portable, and can detect infectious diseases and pathogens in a matter of minutes.